Gut Microbiota: The Potential Key Target of TCM's Therapeutic Effect of Treating Different Diseases Using the Same Method-UC and T2DM as Examples
- PMID: 35433500
- PMCID: PMC9005880
- DOI: 10.3389/fcimb.2022.855075
Gut Microbiota: The Potential Key Target of TCM's Therapeutic Effect of Treating Different Diseases Using the Same Method-UC and T2DM as Examples
Abstract
Traditional Chinese herbal medicine often exerts the therapeutic effect of "treating different diseases with the same method" in clinical practice; in other words, it is a kind of herbal medicine that can often treat two or even multiple diseases; however, the biological mechanism underlying its multi-path and multi-target pharmacological effects remains unclear. Growing evidence has demonstrated that gut microbiota dysbiosis plays a vital role in the occurrence and development of several diseases, and that the root cause of herbal medicine plays a therapeutic role in different diseases, a phenomenon potentially related to the improvement of the gut microbiota. We used local intestinal diseases, such as ulcerative colitis, and systemic diseases, such as type 2 diabetes, as examples; comprehensively searched databases, such as PubMed, Web of Science, and China National Knowledge Infrastructure; and summarized the related studies. The results indicate that multiple individual Chinese herbal medicines, such as Rhizoma coptidis (Huang Lian), Curcuma longa L (Jiang Huang), and Radix Scutellariae (Huang Qin), and Chinese medicinal compounds, such as Gegen Qinlian Decoction, Banxia Xiexin Decoction, and Shenling Baizhu Powder, potentially treat these two diseases by enriching the diversity of the gut microbiota, increasing beneficial bacteria and butyrate-producing bacteria, reducing pathogenic bacteria, improving the intestinal mucosal barrier, and inhibiting intestinal and systemic inflammation. In conclusion, this study found that a variety of traditional Chinese herbal medicines can simultaneously treat ulcerative colitis and type 2 diabetes, and the gut microbiota may be a significant target for herbal medicine as it exerts its therapeutic effect of "treating different diseases with the same method".
Keywords: diabetes mellitus; gut microbiota; inflammation.; intestinal barrier; ulcerative colitis.
Copyright © 2022 Zhang, Liu, Yang, Jin, Ding and Zhao.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Main active components of Jiawei Gegen Qinlian decoction protects against ulcerative colitis under different dietary environments in a gut microbiota-dependent manner.Pharmacol Res. 2021 Aug;170:105694. doi: 10.1016/j.phrs.2021.105694. Epub 2021 Jun 2. Pharmacol Res. 2021. PMID: 34087350
-
[Chinese medicinal formulae treat inflammatory bowel diseases through maintaining gut flora homeostasis].Zhongguo Zhong Yao Za Zhi. 2022 Nov;47(22):5997-6004. doi: 10.19540/j.cnki.cjcmm.20220706.501. Zhongguo Zhong Yao Za Zhi. 2022. PMID: 36471950 Chinese.
-
Shenling Baizhu Decoction treats ulcerative colitis of spleen-deficiency and dampness obstruction types by targeting 'gut microbiota and galactose metabolism-bone marrow' axis.J Ethnopharmacol. 2024 Dec 5;335:118599. doi: 10.1016/j.jep.2024.118599. Epub 2024 Jul 21. J Ethnopharmacol. 2024. PMID: 39043352
-
The linkage of gut microbiota and the property theory of traditional Chinese medicine (TCM): Cold-natured and sweet-flavored TCMs as an example.J Ethnopharmacol. 2023 Apr 24;306:116167. doi: 10.1016/j.jep.2023.116167. Epub 2023 Jan 11. J Ethnopharmacol. 2023. PMID: 36641107 Review.
-
Research Progress in Ulcerative Colitis: The Role of Traditional Chinese Medicine on Gut Microbiota and Signaling Pathways.Am J Chin Med. 2024;52(8):2277-2336. doi: 10.1142/S0192415X24500885. Epub 2024 Dec 31. Am J Chin Med. 2024. PMID: 39756829 Review.
Cited by
-
Gegen Qinlian decoction alleviates depression-like behavior by modulating the gut microenvironment in CUMS rats.BMC Complement Med Ther. 2024 Sep 20;24(1):339. doi: 10.1186/s12906-024-04638-4. BMC Complement Med Ther. 2024. PMID: 39304871 Free PMC article.
-
Effect of gut microbiome regulated Taohong Siwu Decoction metabolism on glioma cell phenotype.Front Cell Infect Microbiol. 2023 Jun 5;13:1192589. doi: 10.3389/fcimb.2023.1192589. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37342242 Free PMC article.
-
Anti-Hyperglycemic Agents in the Adjuvant Treatment of Sepsis: Improving Intestinal Barrier Function.Drug Des Devel Ther. 2022 Jun 4;16:1697-1711. doi: 10.2147/DDDT.S360348. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 35693534 Free PMC article. Review.
-
Repositioning of clinically approved drug Bazi Bushen capsule for treatment of Aizheimer's disease using network pharmacology approach and in vitro experimental validation.Heliyon. 2023 Jun 27;9(7):e17603. doi: 10.1016/j.heliyon.2023.e17603. eCollection 2023 Jul. Heliyon. 2023. PMID: 37449101 Free PMC article.
-
Therapeutic Effects of Intermittent Fasting Combined with SLBZS and Prebiotics on STZ-HFD-Induced Type 2 Diabetic Mice.Diabetes Metab Syndr Obes. 2024 Oct 29;17:4013-4030. doi: 10.2147/DMSO.S474196. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 39492963 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical